Evidence map›Paper›PMID 22307488›Full record

ReviewNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition2012

Zinc and liver disease.

Mohammad K Mohammad, Mohammad K Mohommad, Zhanxiang Zhou, Matthew Cave, Ashutosh Barve, Craig J McClain

Erratum issued Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04834063 (Evaluation of Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients), which is not on this map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04834063 completednot on this mapstarted 2021, after this paper: background citation

Evaluation of Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients

TypeobservationalSponsorSohag UniversityRan2021 to 2021Enrolled80ConditionsNAFLDArmsSerum Zinc a level, serum selenium level, Fibroscan measurement
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 235 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Serum zinc level independently predicts need for inpatient intubation among patients hospitalized with COVID-19: A prospective observational study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Observational
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Investigating the Interplay of Toxic Metals and Essential Elements in Liver Disease.International journal of environmental research and public health · 2024
    Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Mohommad, Mohammad K [corrected to Mohammad, Mohammad K]
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mohammad K MohammadUniversity of Louisville, Louisville, KY, USA.
Mohammad K Mohommad
Zhanxiang Zhou
Matthew Cave
Ashutosh Barve
Craig J McClain
University of Louisville Hospital · USUniversity of Louisville · USUniversity of North Carolina at Greensboro · US

Funding

PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia'R01ES021375 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2012 to 2016
$1.7M
Zinc and Alcohol-Induced Oxidative Liver InjuryR01AA014623 · NIAAA · UNIVERSITY OF LOUISVILLE · PI ZHOU, ZHANXIANG · 2005 to 2009
$1.4M
Zinc supplementation in alcoholic cirrhosisK23AA018399 · NIAAA · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2010 to 2014
$1.0M
Zinc inhibition of endotoxemia in alcoholic liver injuryR01AA016013 · NIAAA · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI ZHOU, ZHANXIANG · 2009 to 2010
$739k
NIAAA NIH HHS K23 AA018399NIAAA NIH HHS R01 AA014623NIAAA NIH HHS R01 AA016013NIEHS NIH HHS R01 ES021375
6 · The paper itself

Abstract

Zinc is an essential trace element required for normal cell growth, development, and differentiation. It is involved in DNA synthesis, RNA transcription, and cell division and activation. It is a critical component in many zinc protein/enzymes, including critical zinc transcription factors. Zinc deficiency/altered metabolism is observed in many types of liver disease, including alcoholic liver disease (ALD) and viral liver disease. Some of the mechanisms for zinc deficiency/altered metabolism include decreased dietary intake, increased urinary excretion, activation of certain zinc transporters, and induction of hepatic metallothionein. Zinc deficiency may manifest itself in many ways in liver disease, including skin lesions, poor wound healing/liver regeneration, altered mental status, or altered immune function. Zinc supplementation has been documented to block/attenuate experimental ALD through multiple processes, including stabilization of gut-barrier function, decreasing endotoxemia, decreasing proinflammatory cytokine production, decreasing oxidative stress, and attenuating apoptotic hepatocyte death. Clinical trials in human liver disease are limited in size and quality, but it is clear that zinc supplementation reverses clinical signs of zinc deficiency in patients with liver disease. Some studies suggest improvement in liver function in both ALD and hepatitis C following zinc supplementation, and 1 study suggested improved fibrosis markers in hepatitis C patients. The dose of zinc used for treatment of liver disease is usually 50 mg of elemental zinc taken with a meal to decrease the potential side effect of nausea.

Indexed as

Dietary SupplementsAnimalsDeficiency DiseasesHepatitis CHumansLiver DiseasesLiver Diseases, AlcoholicTrace ElementsZincTrace ElementsZinc

Identifiers

PMID22307488
PMCPMC6027651
OpenAlexW2115394544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.